O22: A randomized controlled trial of vosoritide in infants and toddlers with achondroplasia

MLA

Carlos Bacino, et al. “O22: A Randomized Controlled Trial of Vosoritide in Infants and Toddlers with Achondroplasia.” Genetics in Medicine Open, vol. 1, no. 1, Jan. 2023. EBSCOhost, https://doi.org/10.1016/j.gimo.2023.100118.

APA

Carlos Bacino, Ravi Savarirayan, William Wilcox, Paul Harmatz, John Phillips, Lynda Polgreen, Louise Tofts, Keiichi Ozono, Paul Arundel, Melita Irving, Donald Basel, Michael Bober, Joel Charrow, Hiroshi Mochizuki, Yumiko Kotani, Howard Saal, George Jeha, Lynn Han, Elena Fisheleva, … Jonathan Day. (2023). O22: A randomized controlled trial of vosoritide in infants and toddlers with achondroplasia. Genetics in Medicine Open, 1(1). https://doi.org/10.1016/j.gimo.2023.100118

Chicago

Carlos Bacino, Ravi Savarirayan, William Wilcox, Paul Harmatz, John Phillips, Lynda Polgreen, Louise Tofts, et al. 2023. “O22: A Randomized Controlled Trial of Vosoritide in Infants and Toddlers with Achondroplasia.” Genetics in Medicine Open 1 (1). doi:10.1016/j.gimo.2023.100118.